Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its
نویسندگان
چکیده
Robert Kleemann, Hans M.G. Princen, Jef J. Emeis, J. Wouter Jukema, Ruud D. Fontijn, Anton Antiinflammatory Effects of Rosuvastatin Lowering Effect in APOE*3-Leiden Transgenic Mice : Evidence for − Plasma Cholesterol Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2003 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000086460.55494.AF 2003;108:1368-1374; originally published online August 25, 2003; Circulation. http://circ.ahajournals.org/content/108/11/1368 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.
BACKGROUND Statins can exert anti-inflammatory antiatherosclerotic effects through an anti-inflammatory action, independent of lowering cholesterol. We addressed the question whether the anti-inflammatory activities of statins can reduce atherosclerosis beyond the reduction achieved by cholesterol lowering per se. METHODS AND RESULTS Two groups of 20 female APOE*3-Leiden mice received either ...
متن کاملComparative Study of Rosuvastatin as Monotherapy Versus Rosuvastatin with Ramipril in Dyslipidemia and Their Effects on Atherosclerosis
Objective: To evaluate the effect of Rosuvastatin as monotherapy versus combination therapy of Rosuvastatin with Ramipril on the Intimo-Media Thickness (IMT) of the carotid arteries in patients of dyslipidemia. Background: Statins have shown to improve the lipid profile in dyslipidemic patients. These have anti-oxidative and anti-inflammatory actions. The statins may have also antiatherosclerot...
متن کاملRosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering
OBJECTIVE Rosuvastatin has been widely used in the primary and secondary prevention of coronary heart disease. However, its antiatherosclerotic properties have not been tested in a mouse model that could mimic human coronary heart disease. The present study was designed to test the effects of rosuvastatin on coronary artery atherosclerosis and myocardial fibrosis in SR-B1 (scavenger receptor cl...
متن کاملRosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
BACKGROUND Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, have anti-inflammatory effects that are independent of their lipid-lowering properties. Despite suppressive antiretroviral therapy (ART), elevated levels of immune activation and inflammation often persist. METHODS The Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV (SATU...
متن کاملRosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
BACKGROUND In chronic human immunodeficiency virus (HIV) infection, plasma cystatin C may be influenced by factors other than glomerular filtration rate such as inflammation. Statins may improve cystatin C by improving glomerular function or by decreasing inflammation. METHODS The Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV (SATURN-HIV) trial randomized 147 p...
متن کامل